@article{article, title  = {{Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials}},

 publisher = {{Springer Science and Business Media LLC}},

 url = {{http://dx.doi.org/10.1007/s10549-023-07147-z }},

 year = {{2023}},

 month = {{12}},

 author = {{Rugo HS and Van Poznak CH and Neven P and Danielewicz I and Lee SC and Campone M and Chik JYK and Vega Alonso E and Naume B and Brain E and Siegel JM et al}},

 doi = {{10.1007/s10549-023-07147-z}},

 volume = {{204}},

 journal = {{Breast Cancer Research and Treatment}},

 issue = {{2}},

 pages = {{249-259}},

 note = {{Accessed on 2025/10/10}}}